ethyl 2-(4-broMophenyl)-2-Methylpropanoate

ethyl 2-(4-broMophenyl)-2-Methylpropanoate Suppliers list
Company Name: Tetranov Biopharm  
Tel: 13526569071
Email: sales@leadmedpharm.com
Company Name: Shanghai YuanQi Biotechnology Co., Ltd.  
Tel: +86-2332782371 +86-18120098618
Email: sales@adobechem.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Adobe Chem Co., Ltd.  
Tel: 2332782371
Email: adobechem@qq.com
Company Name: Aikon International Limited  
Tel: 025-66061636 19370895928
Email: qqyang@aikonchem.com
ethyl 2-(4-broMophenyl)-2-Methylpropanoate Basic information
Product Name:ethyl 2-(4-broMophenyl)-2-Methylpropanoate
Synonyms:ethyl 2-(4-broMophenyl)-2-Methylpropanoate;Benzeneacetic acid, 4-bromo-α,α-dimethyl-, ethyl ester;2-(4-bromophenyl)-2-methylpropanoic acid ethyl ester;Alectinib Impurity 13
CAS:32454-36-7
MF:C12H15BrO2
MW:271.15
EINECS:
Product Categories:
Mol File:32454-36-7.mol
ethyl 2-(4-broMophenyl)-2-Methylpropanoate Structure
ethyl 2-(4-broMophenyl)-2-Methylpropanoate Chemical Properties
storage temp. Sealed in dry,Room Temperature
AppearanceColorless to light yellow Liquid
Safety Information
MSDS Information
ethyl 2-(4-broMophenyl)-2-Methylpropanoate Usage And Synthesis
UsesEthyl 2-(4-Bromophenyl)-2-methylpropanoate is an intermediate of Alectinib (C183360), a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth.
Synthesis
Ethyl 4-bromophenylacetate

14062-25-0

Iodomethane

74-88-4

ethyl 2-(4-broMophenyl)-2-Methylpropanoate

32454-36-7

Example 13A Synthesis of ethyl 2-(4-bromophenyl)-2-methylpropanoate: 2.0 g (8.2 mmol) of ethyl p-bromophenylacetate was dissolved in 50 mL of DMF, and 0.7 g (18 mmol) of a suspension of 60% sodium hydride mineral oil was added slowly at room temperature. The mixture was stirred at room temperature for 30 min before 2.9 g (20.6 mmol) of iodomethane was added. The reaction mixture was continued to stir overnight at room temperature. After completion of the reaction, the reaction mixture was diluted with ethyl acetate and extracted sequentially with water and saturated sodium chloride solution. The organic phase was separated, dried with anhydrous magnesium sulfate, filtered and the filtrate concentrated. The residue was purified by preparative HPLC [Reprosil C18, 10 μm, 250 mm × 40 mm, gradient elution (30% methanol/70% water to 100% methanol), run time 25 min]. After HPLC analysis, the fractions containing the target product were combined and concentrated to give 1.75 g (78% yield) of the product as an oil. The product was characterized by GC-MS [Method 5] and 1H-NMR (400 MHz, DMSO-d6): GC-MS: Rt = 5.10 min; MS (ESIpos): m/z = 270/272 [M+]; 1H-NMR: δ [ppm] = 1.11 (t, 3H), 1.48 (s, 6H), 4.06 (q, 2H ), 7.24-7.29 (m, 2H), 7.50-7.54 (m, 2H).

References[1] Patent: US2016/318866, 2016, A1. Location in patent: Paragraph 0639; 0640; 0641
[2] Patent: WO2011/44187, 2011, A1. Location in patent: Page/Page column 94
[3] Patent: WO2013/40790, 2013, A1. Location in patent: Page/Page column 60
[4] Patent: WO2013/43624, 2013, A1. Location in patent: Page/Page column 59; 60
[5] Patent: EP3239143, 2017, A2. Location in patent: Paragraph 0339
ethyl 2-(4-broMophenyl)-2-Methylpropanoate Preparation Products And Raw materials
Raw materialsEthyl 4-bromophenylacetate-->Iodomethane-->Mineral oil-->N,N-Dimethylformamide-->Sodium hydride
Tag:ethyl 2-(4-broMophenyl)-2-Methylpropanoate(32454-36-7) Related Product Information
Propionic acid 2-(4-Bromophenyl)-2-methylpropionic acid 2-(4-broMophenyl)-2-Methylpropanal 2-(4-broMophenyl)-2-Methylpropan-1-ol Ethyl 2,2-dimethylphenylacetate Ethyl 2-(4-bromophenyl)propanoate